ABP — ABPRO Holdings Share Price
0.000.00%
Last trade - 00:00- $127.51m
- $127.51m
- $2.20m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.59 | ||
| Price to Tang. Book | 9.59 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 57.93 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -85.1% | ||
| Return on Equity | -92.66% | ||
| Operating Margin | -561.43% | ||
Financial Summary
| Year End 31st Dec | Unit | 2013 | 2014 | 2015 | 2016 | 2017 | 2018E | 2019E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 1.69 | 2.2 | n/a | n/a | 30.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).
Directors
- Last Annual
- December 31st, 2017
- Last Interim
- January 1st, 1970
- Incorporated
- May 20th, 2021
- Public Since
- January 14th, 2022
- No. of Employees
- 6
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 2,716,278
- Address
- 6 St Johns Lane, Floor 5, NEW YORK, 10013
- Web
- https://abpro.co/
- Phone
- +1 2488907200
- Auditors
- WOLF & COMPANY, P.C.
Upcoming Events for ABP
Q1 2026 ABPRO Holdings Inc Earnings Release
Similar to ABP
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
Acurx Pharmaceuticals
NASDAQ Capital Market
FAQ
What is the ABPRO Holdings share price?
As of Today at 09:02 UTC, shares in ABPRO Holdings are trading at $6.80. This share price information is delayed by 15 minutes.
How has the ABPRO Holdings share price performed this year?
Shares in ABPRO Holdings last closed at $6.80 and the price had moved by -91.54% over the past 365 days. In terms of relative price strength the ABPRO Holdings share price has underperformed the S&P500 Index by -92.51% over the past year.
What are the analyst and broker recommendations for ABPRO Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the ABPRO Holdings dividend yield?
ABPRO Holdings does not currently pay a dividend.
Does ABPRO Holdings pay a dividend?
ABPRO Holdings does not currently pay a dividend.
When does ABPRO Holdings next pay dividends?
ABPRO Holdings does not currently pay a dividend.
How do I buy ABPRO Holdings shares?
To buy shares in ABPRO Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ABPRO Holdings?
As of the previous close price of $6.80, shares in ABPRO Holdings had a market capitalisation of $127.51m.
Where are ABPRO Holdings shares listed?
Here are the trading details for ABPRO Holdings:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ABP
What kind of share is ABPRO Holdings?
Based on an overall assessment of its quality, value and momentum ABPRO Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ABPRO Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the ABPRO Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ABPRO Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -7.58%.
As of the last closing price of $6.80, shares in ABPRO Holdings were trading -21.59% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ABPRO Holdings PE Ratio?
The ABPRO Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of ABPRO Holdings?
We do not have data on ABPRO Holdings' directors